Skip to main content

Drug Manufacturers - Specialty & Generic

Healthcare

41 US-listed companies tracked

Specialty and generic drug manufacturers develop, produce, and market medications across therapeutic areas, competing on efficacy, cost, and regulatory approval timelines. Key drivers include patent expirations (which trigger generic competition and revenue cliffs), FDA approvals and pipeline success, pricing power influenced by healthcare policy, and input cost volatility in active pharmaceutical ingredients. TrendMatrix ranks 29 US-listed Drug Manufacturers - Specialty & Generic stocks by 10-dimension quantitative score, refreshed every 5 minutes during market hours with a full reanalysis nightly.

Sort:By verdict tierBy scorePure overall_score desc — matches per-stock peer-rank

Ranked stocks

Drug Manufacturers - Specialty & Generic stocks ranked by TrendMatrix score
#SymbolScoreVerdictPriceUpside
1IRWD7.4Buy Wait$3.77+37.5%
2BCRX7.3Buy Wait$8.02+124.8%
3NBIX7.3Buy Wait$136.95+35.9%
4ANIP6.8Hold$72.28+27.3%
5KNSA6.8Sell$79.94+6.7%
6LQDA6.5Buy Wait$34.78+33.8%
7EOLS6.5Sell$7.57+72.4%
8CRON6.4Hold$3.20-34.4%
9SUPN6.4Sell$39.57+32.6%
10BHC6.3Hold$6.31+3.4%
11ETON6.3Hold$51.33+17.6%
12LNTH6.3Hold$99.99-6.9%
13KMDA6.3Sell$7.83+46.6%
14INDV6.2Hold$33.62+23.9%
15COLL6.2Sell$23.18+83.9%
16XERS6.1Hold$10.07+11.1%
17ALKS6.0Hold$40.10+26.3%
18TLRY5.8Sell$3.21+59.6%
19AMRX5.7Sell$19.25+2.7%
20AQST5.7Sell$4.06+100.0%
21PAHC5.7Sell$37.98-1.5%
22ZTS5.6Buy Wait$78.42+5.2%
23GLAS5.5Hold$3.71+115.1%
24ELAN5.5Sell$23.54+14.6%
25TAK5.5Sell$19.45-3.8%
26VTRS5.5Sell$18.22-5.9%
27TKNO5.4Sell$7.60+10.7%
28TRLV5.4Sell$10.30+53.5%
29AMPH5.3Sell$26.42-25.9%
30HIMS5.3Sell$29.38-7.7%
31PRGO5.3Sell$16.48-14.9%
32PBH5.2Sell$49.20+19.9%
33HLN5.1Hold$9.94+4.5%
34UTHR5.1Hold$541.51+4.6%
35AMLX5.0Sell$27.65+33.3%
36HROW5.0Sell$28.75+96.7%
37PCRX4.9Sell$36.33-19.6%
38TEVA4.8Hold$41.11-0.2%
39ALVO4.7Sell$5.31+11.4%
40RDY4.4Sell$12.90-6.8%
41EVO4.2Sell$1.42+153.3%

Related Industries

Last updated 7/5/2026 · 41 stocks tracked · Methodology